Press releases

15
Dec 2025
21:50 E.S.T.

Cellectis Announces Arbitral Decision in Dispute with Servier

Read more
8
Dec 2025
06:30 E.S.T.

ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL

Read more
19
Nov 2025
11:20 E.S.T.

Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells

Read more
7
Nov 2025
21:30 E.S.T.

Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update

Read more
3
Nov 2025
14:15 E.S.T.

Cellectis to Present a Development Update for eti-cel at ASH 2025

Read more
31
Oct 2025
20:30 E.S.T.

Cellectis to Report Third Quarter Financial Results on November 7, 2025

Read more
16
Oct 2025
19:00 E.S.T.

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

Read more
16
Oct 2025
11:00 E.S.T.

Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers

Read more
7
Oct 2025
06:40 E.S.T.

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

Read more
4
Aug 2025
20:30 E.S.T.

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US